INTRODUCTION: The aim of this study was to present the anatomical and functional results of scleral buckling (SB) surgery performed in cases of rhegmatogenous retinal detachment (RRD).
METHODS: Retrospectively, 101 eyes of 101 patients who underwent SB surgery were included in the study. Anatomical success or failure was assessed by slit-lamp microscopy fundus examination. Best corrected visual acuity (BCVA) measurements were performed on all patients at baseline and at control visits. Preliminary and posterior segment examinations were performed with slit-lamp biomicroscopy, and intraocular pressure measurements were performed with Goldman applanation tonometry. The general characteristics of the patients and etiological factors were also examined.
RESULTS: The mean age of the patients was 33±16 years. The most common risk factors were idiopathic causes and myopia, each found in 34.7% of eyes, and trauma in 18.8%. The mean length of disease history was 20.2±20 days. There was no correlation between length of disease history and anatomical and functional success. In all, 94% of the eyes were phakic, 5% were pseudophakic and 1% was aphakic. Macular involvement was present in 37 (36.6%) of eyes. While there was a positive correlation between macular involvement and functional success, there was no significant difference in terms of anatomical success. At the final control, anatomical success was achieved in 67 eyes (66.7%) and functional success in 66 eyes (65%). Pars plana vitrectomy surgery was performed as a second operation in 33.3% of the patients. Before the SB operation, the mean BCVA was 1.2±0.9 logMAR (logarithm of the minimum angle of resolution); afterwards, it increased to 0.6±0.5 logMAR (p<0.001).
DISCUSSION AND CONCLUSION: When SB surgery is performed with the appropriate indications in the treatment of RRD, it is an easy method to apply, has a high success rate, a low complication rate, and provides the option for a secondary surgery if it fails.

INTRODUCTION: The aim of the present study was to report the outcomes of pars plana lensectomy (PPL) combined with pars plana vitrectomy (PPV) in traumatic ectopia lentis performed at a tertiary eye hospital.
METHODS: Patients who underwent PPL combined with PPV for surgical management of traumatic lens subluxation/dislocation in the clinic were retrospectively evaluated. Only patients with at least 6 months follow-up were included in the study.
RESULTS: Sixteen eyes of 16 patients were included in the study. Of the total, 94% of the patients were male and 6% were female. The mean age of the patients was 41±17 years. The mean length of follow-up was 9±5 months. At presentation, 19% of the patients had intravitreal hemorrhage and 38% had retinal detachment. Preoperatively, 19% of the patients had 5/200 or better visual acuity. At the final visit, visual acuity was “hand motion” or better in all patients, and 38% of the patients had 5/200 or better visual acuity. Visual acuity was stable or improved in all patients. Anatomical success was achieved in all patients who had retinal detachment preoperatively.
DISCUSSION AND CONCLUSION: PPL combined with PPV is a safe and effective method of surgical management of traumatic ectopia lentis; however, the associated pathologies determine the final visual outcome and preoperative visual acuity is the most important prognostic factor.

INTRODUCTION: The aim of this study was to evaluate the functional and anatomical outcomes and the rate of epiretinal membrane (ERM) recurrence in eyes that had undergone ERM-internal limiting membrane (ILM) peeling surgery at least 6 months earlier.
METHODS: The records of 81 eyes of 81 patients who underwent pars plana vitrectomy (PPV) and ERM-ILM peeling with the diagnosis of idiopathic ERM between January 2015 and January 2016 in our clinic were retrospectively reviewed. Patients with at least 6 months of follow-up were included. The demographic details of the patients, duration of the follow-up period, use of endotamponade, and any complications were recorded. Best corrected visual acuity and central macular thickness (CMT) at baseline and at 6, 12, and 18 months were also recorded.
RESULTS: A total of 81eyes of 81 patients, 45 (55.6%) males and 36 (44.4%) females, with a group mean age of 65.7±8.5 years (range: 46-85 years) were assessed. The mean preoperative visual acuity was 0.81±0.50 logMAR (the logarithm of the minimum angle of resolution) (0.22 decimals). During the follow-up, the mean visual acuity at 6, 12, and 24 months was 0.61±0.37 logMAR (0.33 decimals), 0.61±0.38 logMAR (0.33 decimals), and 0.55±0.33 logMAR (0.36 decimals), respectively. The visual acuity was significantly better at 6,12, and 24 months compared with the baseline measurement (p<0.05 for all; paired t-test). The mean preoperative CMT was 519±103 μm. During the follow-up, the mean CMT was 302±89 μm, 287±80 μm, and 273±82 μm at 6,12, and 24 months, respectively. Compared with the baseline, a statistically significant difference was observed at 6, 12, and 24 months.
DISCUSSION AND CONCLUSION: PPV with membranectomy and ILM peeling is a safe and effective method to treat idiopathic ERM. It led to a functional improvement and a reduction in macular thickness in most of the patients diagnosed with ERM. The rate of recurrence of ERM and the need for repeat ERM surgery was lower in eyes where the ILM was removed with the ERM than the expected rate for when ERM peeling is performed alone.

INTRODUCTION: The aim of this study was to evaluate the 2-year outcomes of intravitreal ranibizumab (IVR) therapy in combination with photodynamic therapy (PDT) in patients with polypoidal choroidal vasculopathy (PCV).
METHODS: Patients with PCV who presented at the clinic between January 2013 and January 2014 were reviewed retrospectively. Twenty-three eyes of 23 patients were included in this study. Indocyanine green angiography was performed to confirm the diagnosis of PCV in all patients. IVR was administered within a week following PDT, then followed by additional IVR as needed. Best corrected visual acuity (BCVA) measurement, biomicroscopic examination, and central macular thickness (CMT) measurement via optical coherence tomography at baseline and at 3, 6, 12, 18, and 24 months were performed. The mean change in BCVA and CMT at follow-up was compared with the baseline.
RESULTS: A total of 23 eyes of 23 patients were included in this study. The mean age of the patients was 65.8±7.4 years (range: 55-82 years). The mean BCVA (logMAR, or logarithm of the minimum angle of resolution) was 0.68±0.45 at baseline, 0.67±0.45 at 3 months (p=0.24), 0.66±0.45 at 6 months (p=0.43), 0.69±0.43 at 12 months (p=0.95), 0.69±0.42 at 18 months (p=0.54), and 0.70±0.42 at 24 months (p=0.56). The mean CMT was 334.5±99.4 μm at baseline, 313.4±96.1 μm at 3 months (p=0.27), 319.1±106.5 μm at 6 months (p=0.44), 303.52±128.33 μm (p=0.17) at 12 months, 246.6±80.8μm at 18 months (p=0.0001), and 226.9±71.7 μm at 24 months (p=0.0001).
DISCUSSION AND CONCLUSION: Verteporfin PDT administered in combination with IVR was an effective treatment for preserving VA in PCV for a 2-year period. Our results need to be confirmed in further studies in a real-life setting.

INTRODUCTION: The aim of this study was to investigate the potential impact of intravenous (IV) prednisolone treatment on the retinal nerve fiber layer (RNFL) in multiple sclerosis (MS) patients with optic neuritis (ON).
METHODS: The demographic features, systemic illnesses, laboratory results, ophthalmological examination findings and RNFL measurements of 28 MS patients who had IV prednisolone treatment for ON and of 24 MS patients with ON that was not treated were retrieved and reviewed retrospectively.
RESULTS: Of the 52 patients included in the study, 31 were women and 21 were men. The average age in the prednisolone group was 32±7.15 years (range: 28-40 years) and it was 34±.2 years (range: 30-42 years) in patients who did not receive treatment. The initial RNFL in the treatment group was 116.81±5.41μm and it was 78.13±3.94 μm at the third month, while it was 118.2±6.07 μm initially and 80.09±5.18 μm at the third month in the untreated group. There was no statistically significant difference between the groups in the RNLF evaluation (p>0.05).
DISCUSSION AND CONCLUSION: Treatment with IV prednisolone had no distinct effect on RNFL.

In this report the optical coherence tomography (OCT) findings of 2 patients with foveal hypoplasia are presented. One patient had oculocutaneous albinism, which is a frequent cause of foveal hypoplasia, and had decreased visual acuity in both eyes. The second patient did not have an associated disease. The clinical and OCT findings of both patients are summarized.